Navigation Links
American Oriental Bioengineering Reports Third Quarter 2011 Financial Results
Date:11/14/2011

JERSEY CITY, N.J., Nov. 14, 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), (the "Company" or "AOB"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over-the-counter ("OTC") products, today announced financial results for the third quarter ended September 30, 2011.

2011 Third Quarter Financial ResultsTotal Revenue for the third quarter of 2011 was $53.9 million, compared to $91.5 million in the same period of 2010. We strategically shift the products mix, decreasing the manufacturing of certain generic drugs from lower margin products toward higher-margin products in order to minimize the impact from the increased cost of certain raw materials and the continuing government price cut on certain products.

  • Revenue from manufacturing business was $49.1 million for the third quarter of 2011, compared to $ 87.5 million in the same period of 2010.

  • Revenue from pharmaceutical products was $40.3 million in the third quarter of 2011, compared to $77.2 million in the same period of 2010.
  • Revenue from nutraceutical products was $8.8 million in the third quarter of 2011, compared to $10.3 million in the same period of 2010.

  • Revenue from distribution business was $4.9 million for the third quarter of 2011, compared to $4.1 million in the same period of 2010.

  • Gross profit for the third quarter of 2011 was $25.2 million, compared to $47.3 million in the same period of 2010. Gross margin for the third quarter of 2011 was 46.7%, compared to 51.7% in the same period of 2010. The margin pressure was mainly caused by the increased costs of certain raw materials and newly levied urban construction and maintenance tax and educational surcharge to foreign invested companies in China si
    '/>"/>

    SOURCE American Oriental Bioengineering, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. American Oriental Bioengineering to Hold Third Quarter 2011 Earnings Conference Call at 8:00 AM on November 15, 2011
    2. Positive Results from Phase 2 Trial of Mesoblasts Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting
    3. Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH
    4. Novation Applauds the IMS Institute for Healthcare Informatics for Calling Attention to the Drug Shortage Crisis Facing American Hospitals
    5. Keryx Biopharmaceuticals Announces Highlights from Zerenex™ (ferric citrate) Poster Presentations at American Society of Nephrology Kidney Week 2011 Annual Meeting
    6. Telik Announces Telintra Clinical Presentations at the Annual Meeting of the American Society of Hematology
    7. LX2931 Phase 2 Data to be Presented at the American College of Rheumatology Conference
    8. American Oriental Bioengineering Delays Release of its Third Quarter 2011 Financial Results and Earnings Conference Call
    9. Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting
    10. Masimo Awarded the American Association of Respiratory Cares 2011 Zenith Award
    11. Discovery Labs Releases New AFECTAIR™ Performance Data Presented at the American Association for Respiratory Care Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... 22, 2014  Paper Pak Industries, a manufacturer ... ® Body Guard Bio, a disposable, highly ... bacteria and virus while protecting service providers and ... features a rugged, external nylon shell, watertight zipper, ... leak-proof inner chamber that contains contaminated and potentially ...
    (Date:10/22/2014)... 2014  With a vision to ensure safety ... Global Pharmaceutical and Biotech manufacturer selects and implements ... solution to protect their animal health brand.  ... Photo - http://photos.prnewswire.com/prnh/20141021/153439 ... aggregated by the Xyntek and Antares solution is ...
    (Date:10/22/2014)... Abaxis, Inc. (NasdaqGS: ABAX ), ... today reported financial results for the second fiscal quarter ... , Revenues of $53.9 million, up 18% over ... $0.24, up 33% over last year,s comparable quarter. ... Veterinary Reference Laboratories (AVRL) of $3.5 million, up 50% ...
    Breaking Medicine Technology:New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2Xyntek and Antares Serialization Solution Protects Pets Too! 2Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 2Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 5Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 6Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 7Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 8Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 9Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 10Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 11Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 12Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 13Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 14
    ... BOSTON, Nov. 26 Surface Logix, Inc. today announced,that ... an,update of the company,s drug development pipeline at the ... 27-29, 2007 at The,Pierre Hotel in New York City. ... 2007 at 2:50 PM EST., Surface Logix currently ...
    ... GAITHERSBURG, Md., Nov. 26 MedImmune, Inc. today,announced ... first Phase 1 clinical,trial of CAM- 3001, a ... of the granulocyte-macrophage colony stimulating factor,receptor (GM-CSFR). The ... of single doses of CAM-3001 in patients with ...
    Cached Medicine Technology:MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis 2
    (Date:10/22/2014)... there are only 24 hours in a day, that doesn’t seem ... time within their busy schedules for exercise and fitness. Fortunately, one ... get in shape. Here are five ways you can reach your ... Up Your Commute , Consider riding a bike or taking the ... daily routine. If you must use your car to get to ...
    (Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... may be showing a genetic propensity for obesity as toddlers, ... been linked to increased body fat, but the same genes ... the researchers said. At 1 year, kids with these ... 3, however, these genes were linked to excessive weight gain, ...
    (Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. ... in vitro fertilization (IVF) -- the incubation of embryos in ... device inside the vagina, new research suggests. Scientists from ... an INVOcell, might sharply cut costs for pricey IVF procedures ... accessible to those who don,t live near big-city assisted reproduction ...
    (Date:10/20/2014)... Texas (PRWEB) October 20, 2014 The ... the must-have source of thousands of facts, figures and ... countries and 68 medical sector forecast categories the ... with global, regional and national views on the worldwide ... outlook. , The report gives you data for 2010-2019, ...
    (Date:10/20/2014)... (PRWEB) October 20, 2014 ASCNYC ... organization that helps New Yorkers living with HIV/AIDS ... toward health, housing, recovery and self-sufficiency. Each year, ... the local community through their tireless efforts. , ... Marc Shapses , has been selected as this ...
    Breaking Medicine News(10 mins):Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3
    ... , , BUENOS AIRES, ... Inc., as the recipient of its 2009 Customer Value Leadership ... has deployed an effective strategy to continuously add value to ... in the medical imaging market. , , ...
    ... BEIJING, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,Inc. (the ... medical device,company that develops, manufactures and markets advanced,in-vitro diagnostic ... fiscal quarter ended June 30, 2009 ("1Q FY2009"). ... ("FY2009"). , , 1Q FY2009 Highlights, ...
    ... 1 The Global Biomarker,Market report analyzes the biomarker ... studies the major market drivers, restraints,and opportunities for the ... the macro- and micro-markets with respect to different,geographic regions. ... market data tables and in-depth TOC on biomarker,market. Early ...
    ... BEIJING, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China Medical ... leading China-based medical device,company that develops, manufactures and markets ... for the fourth,fiscal quarter ("4Q FY2008") and the full ... 4Q FY2008 Highlights, -- ...
    ... 1 September: The wider use of reperfusion therapy in patients ... Europe. Effective reperfusion therapy in an AMI patient can cut ... by a sudden blockage of a coronary artery, one of ... Effective reperfusion therapy provides a timely and sustainable reopening of ...
    ... A therapy called cardiac resynchronization can significantly delay the progression ... in the New England Journal of Medicine . ... by 41 percent, the study found. "This shows, for the ... hospitalization for heart failure can be delayed with pacing therapy," ...
    Cached Medicine News:Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 2Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 3Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 4Health News:China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 2Health News:China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 3Health News:China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 4Health News:China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 5Health News:China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 6Health News:China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 7Health News:China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 8Health News:China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 9Health News:China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 10Health News:China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 11Health News:China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 12Health News:China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 13Health News:MarketsandMarkets: Global Biomarker Market Worth US$ 20.5 Billion by 2014 2Health News:MarketsandMarkets: Global Biomarker Market Worth US$ 20.5 Billion by 2014 3Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 2Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 3Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 4Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 5Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 6Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 7Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 8Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 9Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 10Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 11Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 12Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 13Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 14Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 15Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 16Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 17Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 18Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 19
    The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
    The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
    The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
    Inquire...
    Medicine Products: